VMWare in talks to buy Pivotal Software; both controlled by Dell

(Reuters) – VMware Inc (VMW.N) and Pivotal Software Inc (PVTL.N) are negotiating a deal for VMWare to acquire Pivotal, according to a regulatory filing from Dell Technologies Inc (DELL.N) on Wednesday, valuing Pivotal, a maker of software development and management tools, at about $4 billion. Pivotal shares jumped 63% to $13.60, while shares of VMWare were down about 3% at […]

Read more

Snap earnings: Well, this could be a doozy of a conference call

When Snap Inc. last reported earnings, the biggest concerns were the redesign of Snapchat and a declining user base. Ah, what an innocent time. In just the first month of 2019, Snap SNAP, +0.29% experienced two controversial executive departures that have raised questions about stability at the young app company. The new, high-profile chief financial officer — Tim Stone, who was […]

Read more

UPDATE: Bristol-Myers offers update on liver cancer trial, to sell Otezla to hasten close of Celgene deal

Bristol-Myers Squibb Co. shares BMY, +0.92% fell 4% in premarket trade Monday, after the company said a late-stage study of its Opdivo as a treatment for a type of liver cancer failed to meet its main goals. The company said the Phase 3 study called CheckMate -459 evaluating Opdivo versus sorafenib as a first-line treatment in patients with unresectable hepatocellular […]

Read more

This big Wall Street bear warns his bleak scenario for 2019 is taking shape

Why are stocks busting out all of a sudden? Last week, tariffs on Mexico increased the chances that the Fed would cut rates. Investors obviously like that. So, stocks rallied. This week, Trump backs off those same tariffs. Investors apparently like that, too. Stocks again are rallying. Josh Brown of Ritholtz Wealth Management, please explain. “The market wanted to go […]

Read more
1 2 3 9